Friday 7 August 2020
Home      All news      Contact us      India
ndtv.com - 1 month ago

Centre Revises Dosage Of Anti-Viral Drug Remdesivir To COVID-19 Patients

The Union health ministry on Friday revised the dosage of anti-viral drug remdesivir to be administered to coronavirus patients in the moderate stage of illness from the earlier six days to five days...


Latest News
Hashtags:   

Centre

 | 

Revises

 | 

Dosage

 | 

Viral

 | 

Remdesivir

 | 

COVID

 | 

Patients

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources